Emmaus Life Sciences EMMA
OTC EMMA
$0.06 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Selling, General & Administrative (2010 - 2026)

Updated

Emmaus Life Sciences' Selling, General & Administrative came in at $1.57 million for Q2 2026, down 31.8% from $2.31 million a year earlier and down 14.9% from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Emmaus Life Sciences reported Selling, General & Administrative of $6.96 million, down 28.5% year-over-year; for FY2025, it was $8.18 million, down 23.5% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of -9.8% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $10.69 million in FY2024 (-28.2%), $14.89 million in FY2023 (+13.1%), $13.17 million in FY2022 (-2.0%) and $13.44 million in FY2021 (-1.8%).
  • The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q3 2017.
  • Year-over-year, Selling, General & Administrative has declined for 12 consecutive quarters, with an average decline of 21.7% over the last eight quarters.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2023 (growth of 44.9%), and the weakest in Q1 2024 (a decline of 41.2%).
  • Business Quant data shows EMMA's Selling, General & Administrative at $1.85 million (Q1 2026), $1.8 million (Q4 2025) and $1.73 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 6.29 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 3.63 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 5.65 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 1.92 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 3.41 Bn
10 Emmaus Life Sciences 4.21 Mn -2.09 Mn 5.97 Mn 1.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.57 Mn
Mar 31, 2026 1.85 Mn
Dec 31, 2025 1.80 Mn
Sep 30, 2025 1.73 Mn
Jun 30, 2025 2.31 Mn
Mar 31, 2025 2.34 Mn
Dec 31, 2024 2.29 Mn
Sep 30, 2024 2.80 Mn
Jun 30, 2024 2.73 Mn
Mar 31, 2024 2.87 Mn
Dec 31, 2023 3.07 Mn
Sep 30, 2023 2.87 Mn
Jun 30, 2023 4.07 Mn
Mar 31, 2023 4.88 Mn
Dec 31, 2022 3.76 Mn
Sep 30, 2022 2.96 Mn
Jun 30, 2022 3.08 Mn
Mar 31, 2022 3.37 Mn
Dec 31, 2021 3.28 Mn
Sep 30, 2021 3.36 Mn
API Access

Emmaus Life Sciences Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=EMMA&period=max&api_key=YOUR_API_KEY